MAPK inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11273153
APP PUB NO 20180289684A1
SERIAL NO

16006308

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to certain novel substituted thiophene compounds and the finding that they display useful efficacy in the inhibition of the p38α MAPK enzyme. This provides for use of the compounds in various treatment methodologies related to MAPK inhibition, including the treatment of inflammation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EVERBRILLIANT PHARMA PTY LTDMELBOURNE VIC 3000

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chalmers, David Clayton, AU 7 38
Krum, Henry Malvern, AU 4 12
Scammells, Peter North Balwyn, AU 4 23
Simpson, Jamie Brunswick, AU 17 32
Vinh, Natalie Vermont South, AU 2 0
Wang, Bing Camberwell, AU 403 3504

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 15, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 15, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 15, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00